December 6, 2017 PR-M12-17-NI-001
Ravensburg, December 6, 2017 — In addition to being a leading global contract development and manufacturing organization, Vetter is also a leader in the area of occupational health management. That is the conclusion reached by the initiative Corporate Health Award, which annually recognizes companies that have made an above-average contribution to their employees’ healthcare and pursues a sustainable HR strategy. In this context, Vetter has been acknowledged for excellence in the category of ‘chemical and pharma industry’. The Corporate Health Award, now in its ninth year, is one of a number of well-known initiatives that focus on occupational health management. With a workforce of around 4,300 employees, Vetter supports its customers in the development, aseptic manufacturing and packaging of injectable drugs, including those for the world’s top 20 companies in the pharma and biotech sector.
The provider of prefilled drug-delivery systems sees this recognition as further proof of having adopted the correct strategy, as it pertains to occupational health management. “Our clients value the high quality we offer in realizing various projects, often those involving highly complex pharmaceutical or biotechnological undertakings,” said Vetter Managing Director Peter Soelkner. “As a company that operates in the healthcare sector, it is a matter of course for us to apply this essence of quality across the board, including those actions concerning the healthcare services we offer our own employees. The well-being and good health of all the staff are important in this respect.” Each year, the family-owned enterprise invests a six-figure sum in realizing and further expanding its health management services, headed by Petra Hagel.
Participation in the Corporate Health Award is contingent upon the completion of a comprehensive audit in which independent experts analyse the quality and effectiveness of a company’s occupational health management. Among other items, they look specifically at the offering of health-promoting services, innovative processes, and the interlocking of the program with the individual executive level. “The individual audits we perform are in-depth. We examine how sustainably a programme has been incorporated into a company’s structure and how its employees can benefit,” says Markus A.W. Hoehner, CEO of the market research company EuPD Research Sustainable Management GmbH, and one of the initiators of the Corporate Health Award. “We find that Vetter has a well-planned and highly structured concept in place,” explained Hoehner. “The entire program is holistic in design and therefore offers the employees real added value.”
“With our occupational health management, which is managed under the title ‘Vetter Health’, the company offers all employees the opportunity to do something positive for themselves and incorporates their overall health,” said Soelkner. “In doing so, we also highlight those factors we consider to be the most important to our company’s success story, namely, the employees.” Vetter Health comprises an array of occupational health management measures covering the areas of the working world, support services, family and health.
Vetter Pharma International GmbH
Corporate Spokesperson / Specialist External Communications
Phone: +49 (0)751-3700-3729
Nice Insight, established in 2010, is the research division of That’s Nice, A Science Agency, providing data and analysis from proprietary annual surveys, custom primary qualitative and quantitative research as well as extensive secondary research. Current annual surveys include The Nice Insight Contract Development & Manufacturing (CDMO/CMO), Survey The Nice Insight Contract Research - Preclinical and Clinical (CRO) Survey, The Nice Insight Pharmaceutical Equipment Survey, and The Nice Insight Pharmaceutical Excipients Survey.
Headquartered in Ravensburg, Germany, Vetter is a global leading contract development and manufacturing organization (CDMO) with production facilities in Germany and the United States. The company has long-term experience offering services ranging from early development support including clinical manufacturing, to commercial supply and various packaging solutions for vials, syringes and cartridges. Vetter’s customers range from small and midsize to the world’s top 20 pharmaceutical and biotech companies. As a leading solution provider, the CDMO recognizes its responsibility in supporting the needs of its customers in developing devices that contribute to increased patient safety, convenience, and enhanced compliance. Learn more about Vetter at www.vetter-pharma.com.